Skip Navigation
Skip to contents

Intest Res : Intestinal Research

Search
Advanced Search
IMPACT FACTOR
mobile search button mobile menu button

Articles

Page Path
HOME > Intest Res > Volume 12(4); 2014 > Article
Review Impact of Sigmoidoscopy and Colonoscopy on Colorectal Cancer Incidence and Mortality: An Evidence-Based Review of Published Prospective and Retrospective Studies
Otto S. Lin, Richard A. Kozarek, Jae Myung Cha1
Intestinal Research 2014;12(4):268-274.
DOI: https://doi.org/10.5217/ir.2014.12.4.268
Published online: October 27, 2014

Digestive Disease Institute, Virginia Mason Medical Center; Gastroenterology Division, University of Washington School of Medicine, Seattle, WA, USA.

1Gastroenterology Division, Kyung Hee University Hospital at Gang Dong, Kyung Hee University School of Medicine, Seoul, Korea.

Correspondence to Otto S. Lin, C3-Gas, Gastroenterology Section, Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, WA 98101, USA. Tel: +1-206-625-7373 ext. 67694, Fax: +1-206-223-6379, Otto.Lin@vmmc.org
• Received: August 6, 2014   • Revised: August 9, 2014   • Accepted: August 9, 2014

© Copyright 2014. Korean Association for the Study of Intestinal Diseases. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 9,111 Views
  • 35 Download
  • 63 Web of Science
  • 58 Crossref
Full Article

Download PDF Download PDF

  • Screening for colorectal cancer (CRC) using sigmoidoscopy or colonoscopy is now common in many developed countries. This concise, evidence-based review looks at the impact of sigmoidoscopy or colonoscopy screening on CRC incidence, CRC mortality and overall mortality. Data from controlled retrospective and prospective (observational or randomized) studies have generally shown that sigmoidoscopy and colonoscopy, whether for diagnostic, screening or surveillance purposes, are associated with a significant reduction in CRC incidence and CRC mortality. The data on their impact on overall mortality is much more limited, with most studies unable to report a reduction in overall mortality. The results of three meta-analyses have confirmed these conclusions. As expected, sigmoidoscopy has a predominant effect on left-sided CRC, although some studies have shown modest effects on right-sided colon cancer as well. Most studies on colonoscopy have demonstrated that the protective effect applies to both right and left-sided cancer, although the protection seemed better on the left side. Despite the introduction of other screening and diagnostic modalities for the colon, such as computed tomography colonography and colonic capsule endoscopy, lower endoscopy will continue to be an important mode of screening for CRC and evaluating the colon.
  • Keywords: Colon; Colonoscopy; Neoplasms; Screening; Sigmoidoscopy
Screening for colorectal cancer (CRC) in average-risk or high-risk patients has become the standard of care in most developed countries. Such screening can be accomplished by various modalities, including fecal occult blood testing, fecal DNA testing, CT colonography and colonic capsule endoscopy, but in many countries, particularly the United States, the dominant screening methods are endoscopy (i.e., flexible sigmoidoscopy and colonoscopy). This evidence-based review looks at the impact of sigmoidoscopy and colonoscopy on CRC incidence, CRC mortality and overall mortality. Because the purpose is to look at the effect of sigmoidoscopy and colonoscopy on the general population, studies that focus only on patients who underwent polypectomy were not included.
Flexible sigmoidoscopy has long been used for CRC screening, and continues to be popular in many countries. It has the advantages of being more widely available (it can be competently performed by appropriately trained primary care providers, surgeons, or even non-physician providers), quicker (the procedure time is shorter and there is often no need for sedation), more convenient (no need for whole colon bowel preparation) and less expensive than colonoscopy. If an adenoma is discovered on sigmoidoscopy, then typically full colonoscopy is recommended because of the increased risk of a synchronous colonic neoplasm. Removal of large polyps with cautery snare polypectomy cannot be performed because of the risk of explosion since these patients have not undergone a full bowel preparation. Despite its undoubted efficacy, cross-sectional studies have shown that sigmoidoscopy may miss a substantial portion of right-sided colonic neoplasia in patients without concurrent left-sided neoplasia.1,2
There is a substantial body of literature looking at the impact of sigmoidoscopy on CRC incidence (Tables 1 and 2). The earliest evidence was provided by an American retrospective case-control study,3 and subsequently there have been a series of other case-control studies from various countries confirming that sigmoidoscopy is associated with a reduction in CRC incidence.4,5,6,7,8 Case-control studies typically present their findings as OR, which closely approximate risk ratios in low-prevalence conditions or outcomes; thus, an OR of <1.0 implies a protective effect of the "exposure", in this case sigmoidoscopy, against an undesired outcome, for the purposes of this review either CRC development or mortality.
In one of the earliest studies on this topic, 16,351 U.S. Veterans Administration Health Care System patients with CRC were compared against age- and sex-matched controls.3 The OR for exposure to previous sigmoidoscopy was 0.56 [0.46-0.67] for colon cancer and 0.61 [0.49-0.75] for rectal cancer occurrence. This was followed by a population-based case-control study involving 1,048 subjects with colon cancer (rectal cancers were excluded), with an OR of 0.56 [0.44-0.77] for men and 0.53 [0.33-0.77] for women.4 A case-control study from Germany then showed an OR of 0.28 [0.16-0.48] for lower endoscopy (mostly sigmoidoscopy), with the protective effect extending for >10 years.5 Another population-based case-control study on 1,668 patients with CRC against 1,294 controls reported an OR of 0.24 [0.17-0.33]; this study also showed a protective effect extending for as long as 16 years.6 These results were echoed by a Canadian case-control study with 971 cases and 1,944 controls from the Ontario Cancer Registry, the OR being 0.59 [0.46-0.76].7 Finally, a recent American case-control study with 471 cases and 509 controls showed an OR of 0.50 [0.36-0.70] for sigmoidoscopy exposure.9 Against all this evidence, the only contradicting data come from two Dutch studies, one a retrospective cohort and the other a case-control study, both of which found only non-significant trends towards reduction in CRC incidence with sigmoidoscopy.8,10
Prospective non-randomized controlled studies have also shown that sigmoidoscopy is associated with reduction in CRC incidence.11,12 An earlier study on 24,744 men from a long-term prospective observational study, the Health Professionals Follow-up Study, showed a relative risk for CRC of 0.58 [0.36-0.96] after a follow-up of 8 years after lower endoscopy (mostly sigmoidoscopy).11 More recently, a better designed study utilizing 22-year data from the Nurses Health Study, with 57,166 female subjects, as well as the Health Professionals Follow-up Study, with 31,736 male subjects, demonstrated convincingly that CRC incidence reduction was linked to screening sigmoidoscopy, with a relative risk of 0.60 [0.53-0.68] after negative sigmoidoscopy.12
Randomized controlled trials provide the most important data on sigmoidoscopy and CRC incidence.13,14,15,16,17 The pivotal studies are the United Kingdom Flexible Sigmoidoscopy Trial, which showed a reduction in CRC incidence of 23% amongst 57,237 subjects in the screening group,13 the Italian 'Screening for COlon and REctum (SCORE)' study, which showed a reduction of 18% amongst 17,148 subjects randomized to screening sigmoidoscopy,17 and the U.S. Prostate, Lung and Colorectal Cancer (PLCO) Trial, which showed an incidence reduction of 21% amongst 77,445 screening subjects.16 Prior to this, there were three less conclusive randomized trials that also looked at the effectiveness of sigmoidoscopy in preventing CRC.14,15,18 In the Kaiser Permanente Multi-phasic Evaluation Study, even though the incidence of CRC in the study group (who underwent screening with various modalities) was lower than in the controls (4.3 versus 6.7 cases per persons), a retrospective analysis of the trial data did not show any significant difference in exposure to sigmoidoscopy.14 In the small Telemark Polyp Study from Norway, which randomized 799 individuals, the relative risk was 0.2 [0.03-0.95].15 Finally, the Norwegian Colorectal Cancer Prevention (NORCCAP) trial, a much larger, 7-year trial also from Norway (with 55,736 participants, half of whom were screened with one-time sigmoidoscopy) reported a non-significant relative risk of 0.73 [0.47-1.13].18 It is generally believed that the negative results of the NORCCAP trial were due to excessively short follow-up time.
As expected, most of the studies found that sigmoidoscopy had a protective effect for left-sided CRCs only;6,7,9,11,13,17 in some studies, there were trends towards small protective effects for right-sided colon cancer, but these rarely reached statistical significance, except in the largest studies.12,16 One study that excluded rectal cancers still showed only left-sided benefit when comparing proximal against distal colon cancers.4
Not only does sigmoidoscopy reduce the incidence of CRC, but there is now convincing evidence that sigmoidoscopy reduces CRC-specific mortality as well (Tables 1 and 2). However, data on its impact on overall or all-cause mortality are limited and do not demonstrate a benefit at this time.
The earliest evidence of the effect of sigmoidoscopy on CRC mortality came from retrospective case-control studies.19,20,21 Early on, a small case-control study, with only 66 cases and 196 controls, reported an OR of 0.21 [0.08-0.52], suggesting a strong protective effect of sigmoidoscopy against CRC mortality.19 This was followed by a larger case-control study, this time with 261 cases and 868 controls from the Kaiser Permanente Health System, confirming mortality reduction with an adjusted OR of 0.41 [0.25-0.69].20 A few years later, an even larger Veterans Administration Health Care study involving 4,411 patients who died from CRC (each matched to four controls) showed an OR of 0.66 [0.54-0.82].21 The only exception has been a small case-control with 653 subjects which failed to show any reduction in CRC mortality.22
Two previously described prospective non-randomized controlled studies also looked at CRC mortality.11,12 The earlier study, based on male subjects from the Health Professionals Follow-up Study, found an age-adjusted relative risk of 0.56 [0.20-1.60], denoting a trend towards a protective effect of sigmoidoscopy against CRC death.11 More recent analysis of 22 year follow-up data from both the Nurses Health Study and Health Professionals Follow-up Study demonstrated a relative risk of 0.59 [0.45-0.76], confirming this protective effect.12
Similar to the situation with CRC incidence, randomized controlled trials provide the most important data on the efficacy of sigmoidoscopy in reducing CRC mortality.13,14,16,17 The results of the initial studies were somewhat ambivalent. The Kaiser Permanente Multi-phasic Study showed lower CRC mortality in the group randomized to screening, but retrospective analysis of screening exposure showed that patients in the screening group were not more likely to have undergone sigmoidoscopy.14 In contrast, by intention-to-treat analysis, the Italian SCORE Trial showed a reduction of 22% for CRC mortality, which did not reach statistical significance, but per protocol analysis resulted in a significant 38% reduction.17 Other early randomized studies were not able to demonstrate beneficial effects of sigmoidoscopy on CRC mortality.15,18 In the last few years, more conclusive data became available from the United Kingdom Flexible Sigmoidoscopy Trial, which showed a significant reduction in CRC mortality of 31%,13 while the American PLCO Trial showed a reduction of 26%.16
With regard to overall mortality, the data to date have been less encouraging. None of the available randomized controlled trials were able to demonstrate any improvement in overall mortality,13,14,16,17,18 and one even reported increased overall mortality in those who underwent sigmoidoscopy.15 The reason for this lack of benefit is unclear, but may be due to occasional complications from the sigmoidoscopies or the associated follow-up colonoscopies, or from non-gastrointestinal comorbid conditions in the screened patients that diluted the protective effect of sigmoidoscopy.
Just like with CRC incidence, the impact of sigmoidoscopy is expected to be much more pronounced for left-sided CRC mortality than right-sided mortality, and indeed most studies found mortality protection only from left-sided CRCs,4,8,13,14,16,17,19,20 although there were a few notable exceptions.12,21
The use of colonoscopy for screening purposes has only become popular in the last 15 years or so in a few relatively affluent countries, the principal one being the United States, which is responsible for the majority of the world's colonoscopies. Nevertheless, evidence for its efficacy at reducing CRC incidence and mortality is steadily accumulating, although randomized controlled data are still limited. Colonoscopy has several advantages over sigmoidoscopy: it evaluates both the left and right colon, and, since patients have undergone a full bowel preparation, large polyps can be removed at the time of screening using cautery snare polypectomy or even argon plasma coagulation, if needed. Furthermore, colonoscopy is usually performed by gastrointestinal specialists, with a higher level of expertise than generalists.
There is mounting evidence that colonoscopy leads to a subsequent reduction in CRC incidence (Tables 1 and 2). Retrospective case-control studies provided the initial data.3,7,8,9,23 Five studies from various countries, previously described, included patients who had been exposed to either sigmoidoscopy or colonoscopy, but if we stratify the data it is clear that colonoscopy is associated with decreased incidence of CRC, with an OR of 0.47 [0.37-0.58] (for colon cancer) and 0.61 [0.48-0.77] (rectal cancer) in the Veterans Administration Health System study,3 0.29 [0.15-0.58] in another American study,9 0.70 [0.57-0.87] in a Canadian study,7 0.23 [0.19-0.27] in a German study,23 and 0.45 [0.20-0.98] in a Dutch study.8 In addition, a German retrospective cohort study with 586 screened patients and 2,701 controls found a relative risk of 0.52 [0.37-0.73] for advanced neoplasia incidence.24
More recently, large prospective non-randomized controlled studies have also shown reduction in CRC incidence, with a relative risk of 0.44 [0.38-0.52] (after negative colonoscopy) reported from the Nurses Health Study and Health Professionals Follow-up Study.12 A single-cohort prospective observational study on 715 subjects supported these findings by showing a 67% reduction in CRC incidence when compared to historical controls (from the Surveillance, Epidemiology, and End Results database),25 while a prospective controlled study that followed 22,686 subjects for 6 years also reported decreased CRC incidence with an adjusted OR of 0.31 [0.16-0.59].26 Currently, there are no randomized controlled data on the impact of colonoscopy on CRC incidence, although there are some ongoing trials (e.g., the Nordic-European Initiative on Colorectal Cancer [NordICC] trial, comparing screening colonoscopy versus no screening; and the CONFIRM trial, comparing screening colonoscopy versus fecal occult blood testing) that may provide some findings in the near future.
Although colonoscopy is supposed to evaluate the entire colon, some studies still showed a left-sided effect, with no protection against right-sided cancer development.7,8 However, most studies demonstrated protection against both left-sided and right-sided cancers.3,9,12,23,26
There is now reasonably robust evidence from several sources that exposure to colonoscopy, whether screening or diagnostic, is associated with a reduction in CRC mortality (Tables 1 and 2). Similar to the research on CRC incidence, retrospective studies account for most of the evidence in this area.21,27,28
Earlier on, a before-mentioned Veterans Administration Health Care System study that included patients who had undergone sigmoidoscopy or colonoscopy showed a protective effect for colonoscopy once the data were stratified (OR 0.43 [0.30-0.63]).21 Subsequently, two large studies using administrative data from the Canadian national health insurance system reported an association between colonoscopy and decreased CRC mortality, with an OR of 0.69 [0.63-0.74] for the Ontario case-control study (with 10,292 cases and 51,460 controls),27 and a risk reduction of 29% for the Manitoba retrospective cohort study (with a total of 54,803 subjects compared against historical controls).28 In the same vein, a retrospective analysis on 1,071 CRC patients not only showed improved survival in those whose cancers were detected by screening as opposed to symptoms, but also a "stage-shift" as well, i.e., higher probability of cancers being detected at an earlier stage.29
With regard to prospective data, the main evidence comes again from the Nurses Health Study and Health Professionals Follow-up Study, which found a 68% reduction in CRC mortality for patients who had undergone screening colonoscopy.12 Another prospective cohort study, previously described, supported this with an OR of 0.12 [0.01-0.93] for CRC mortality.26 There are currently no randomized controlled data on the effect of colonoscopy on CRC mortality.
Both retrospective Canadian studies showed a strong left-sided effect, with no protection against mortality from right-sided cancers at all.27,28 However, other studies have shown a reduction in proximal cancer mortality,21 including a 53% reduction seen in the largest prospective study to date.12
In conclusion, lower endoscopy is an effective and widely used modality for evaluating the colon and for CRC screening. Studies have generally shown that sigmoidoscopy and colonoscopy, whether for diagnostic, screening or surveillance purposes, is associated with a reduction in CRC incidence and CRC mortality. The data regarding their impact on overall mortality is much more limited at this time. No major study has been able to show a significant reduction in overall mortality from either sigmoidoscopy or colonoscopy. This may be partly explained by the phenomena of non-adherence ("screening" subjects who did not actually undergo lower endoscopy) and contamination ("controls" who actually underwent lower endoscopy as part of routine clinical care), both of which result in underestimation of the effects of lower endoscopy. As expected, sigmoidoscopy has a predominant effect on left-sided CRC, although some studies have shown modest effects on right-sided colon cancer as well, presumably due to discovery of proximal colon cancers associated with synchronous distal polyps. The added value of colonoscopy over sigmoidoscopy has been the subject of some controversy. Some earlier retrospective studies have suggested that the protective effect of colonoscopy on right-sided colon cancers is minimal or non-existent, possibly due to suboptimal bowel preparation and the tendency of flat sessile serrated adenomas to occur in the right colon. However, these studies, though boasting large sample sizes, were based exclusively on claims data and potentially subject to bias;27,28 for example, colonoscopy completion rates might be over-reported during billing to ensure payment for a complete examination even when the cecum or right colon has not been comprehensively examined. Subsequent retrospective and prospective studies have demonstrated that the protective effect applies to both right and left-sided cancer, although usually the protection was better on the left side. Despite the introduction of other screening and diagnostic modalities, such as CT colonography and colonic capsule endoscopy, lower endoscopy will continue to be an important method for CRC screening and colon evaluation. Efforts should continue to be made for improving access and examination quality, with particular focus on enhancing bowel preparation and withdrawal technique.

Financial support: None.

Conflict of interest: None.

  • 1. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169–174.PMID: 10900275.ArticlePubMed
  • 2. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162–168.PMID: 10900274.ArticlePubMed
  • 3. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904–910.PMID: 7486484.ArticlePubMed
  • 4. Slattery ML, Edwards SL, Ma KN, Friedman GD. Colon cancer screening, lifestyle, and risk of colon cancer. Cancer Causes Control 2000;11:555–563.PMID: 10880038.ArticlePubMed
  • 5. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001;85:972–976.PMID: 11592768.ArticlePubMedPMC
  • 6. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622–625.PMID: 12697855.ArticlePubMedPDF
  • 7. Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control 2005;16:865–875.PMID: 16132797.ArticlePubMed
  • 8. Mulder SA, van Soest EM, Dieleman JP, et al. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. Eur J Gastroenterol Hepatol 2010;22:437–443.PMID: 19952765.ArticlePubMed
  • 9. Doubeni CA, Weinmann S, Adams K, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 2013;158:312–320.PMID: 23460054.ArticlePubMedPMC
  • 10. Blom J, Yin L, Liden A, et al. A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening: importance of self-selection. Cancer Epidemiol Biomarkers Prev 2008;17:1163–1168.PMID: 18483338.ArticlePubMed
  • 11. Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 1998;9:455–462.PMID: 9794179.ArticlePubMed
  • 12. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369:1095–1105.PMID: 24047059.ArticlePubMedPMC
  • 13. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624–1633.PMID: 20430429.ArticlePubMed
  • 14. Selby JV, Friedman GD, Collen MF. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. J Clin Epidemiol 1988;41:427–434.PMID: 3367172.ArticlePubMed
  • 15. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414–420.PMID: 10365903.ArticlePubMed
  • 16. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345–2357.PMID: 22612596.ArticlePubMedPMC
  • 17. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst 2011;103:1310–1322.PMID: 21852264.ArticlePubMedPDF
  • 18. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846PMID: 19483252.ArticlePubMedPMC
  • 19. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572–1575.PMID: 1404450.ArticlePubMedPDF
  • 20. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653–657.PMID: 1736103.ArticlePubMed
  • 21. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741–1748.PMID: 7654107.ArticlePubMed
  • 22. Scheitel SM, Ahlquist DA, Wollan PC, Hagen PT, Silverstein MD. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. Mayo Clin Proc 1999;74:1207–1213.PMID: 10593348.ArticlePubMed
  • 23. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:22–30.PMID: 21200035.ArticlePubMed
  • 24. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010;102:89–95.PMID: 20042716.ArticlePubMedPDF
  • 25. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770–775.PMID: 19268269.ArticlePubMed
  • 26. Manser CN, Bachmann LM, Brunner J, Hunold F, Bauerfeind P, Marbet UA. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc 2012;76:110–117.PMID: 22498179.ArticlePubMed
  • 27. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1–8.PMID: 19075198.ArticlePubMed
  • 28. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139:1128–1137.PMID: 20600026.ArticlePubMed
  • 29. Amri R, Bordeianou LG, Sylla P, Berger DL. Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg 2013;148:747–754.PMID: 23784448.ArticlePubMed
Table 1
Prospective Studies on the Impact of Sigmoidoscopy or Colonoscopy on Colorectal Cancer (CRC) Incidence and Mortality
ir-12-268-i001.jpg

*Reduction in CRC mortality and all-cause mortality was statistically significant for the screened group in per-protocol analysis but not in intention-to-treat analysis.

RCT, Randomized controlled trial; SEER, Surveillance, Epidemiology, and End Results; Δ, change; NA, not available.

Table 2
Retrospective Studies on the Impact of Sigmoidoscopy or Colonoscopy on Colorectal Cancer (CRC) Incidence and Mortality
ir-12-268-i002.jpg

*Rectal cancers were excluded from this study.

†Statistically significant for colonoscopy but not sigmoidoscopy.

AN, advanced neoplasia; NA, not available; Δ, change.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Risk factors associated with false-positive fecal immunochemical test results in colorectal cancer screening
      Iqtida Ahmed Mirza, Fan-Yi Meng, Zhongxue Han, Pei-Zhu Wang, Yue-Yue Li, Yan Zhang, Ming-Jun Ma, Xiu-Li Zuo, Yan-Qing Li, Ru-Chen Zhou
      Scientific Reports.2026;[Epub]     CrossRef
    • Cracking the Code of Colorectal Cancer Screening: An Overview With a Focus on Current and Emerging Screening Methods
      Hari Prasad Naidu Boyapati, Sidra Tahreem Hashmi Syeda, Arivudainambi Saravanan, Divya Payidiparty, Prasanna Kumar Anbazhagan
      Cureus.2025;[Epub]     CrossRef
    • Colorectal cancer screening: A review of current knowledge and progress in research
      Sara Ramos Lopes, Claudio Martins, Inês Costa Santos, Madalena Teixeira, Élia Gamito, Ana Luisa Alves
      World Journal of Gastrointestinal Oncology.2024; 16(4): 1119.     CrossRef
    • Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
      Vladislava Stojic, Natasa Zdravkovic, Tamara Nikolic-Turnic, Nebojsa Zdravkovic, Jelena Dimitrijevic, Aleksandra Misic, Kristijan Jovanovic, Stefan Milojevic, Jelena Zivic
      Open Medicine.2023;[Epub]     CrossRef
    • Antihypertensive medications and risk of colorectal cancer in British Columbia
      Jia Qi, Parveen Bhatti, John J. Spinelli, Rachel A. Murphy
      Frontiers in Pharmacology.2023;[Epub]     CrossRef
    • Unmasking the Silent Threat: Colorectal Cancer’s Alarming Surge in India’s Young Adults
      Divya Mahajan
      Journal of Surgical Specialties and Rural Practice.2023; 4(3): 111.     CrossRef
    • Risk of post-polypectomy bleeding after endoscopic mucosal resection in patients receiving antiplatelet medication: comparison between the continue and hold groups
      Sang Hyun Park, Soo-Kyung Park, Hyo-Joon Yang, Yoon Suk Jung, Jung Ho Park, Chong Il Sohn, Dong Il Park
      Surgical Endoscopy.2022; 36(9): 6410.     CrossRef
    • Does Finding Cecal Adenoma Increase the Risk of Discovering More and Advanced Adenomas in the Remainder of the Colon?
      Mahum Nadeem, Pratyusha Parava M, Hussein Bitar, Muhammad Hanafi, Sultan Mahmood, Rabia Saleem, Mohammad F. Madhoun
      Southern Medical Journal.2022; 115(9): 693.     CrossRef
    • Rising colorectal cancer in young adults
      Amol Patel, Vivek Hande
      Indian Journal of Cancer.2022; 59(3): 307.     CrossRef
    • Prophylactic clipping after endoscopic mucosal resection of large nonpedunculated colorectal lesions: A meta‐analysis
      Tsung‐Chieh Yang, Yi‐Hui Wu, Pei‐Chang Lee, Chung‐Yu Chang, Hsiao‐Sheng Lu, Yu‐Jen Chen, Yi‐Hsiang Huang, Fa‐Yauh Lee, Ming‐Chih Hou
      Journal of Gastroenterology and Hepatology.2021; 36(7): 1778.     CrossRef
    • Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines
      Tao Zhang, Ling Hu, Jia-Feng Tang, Hang Xu, Kuan Tian, Meng-Na Wu, Shi-Ying Huang, Yu-Mei Du, Peng Zhou, Rui-Jin Lu, Shuang He, Jia-Mei Xu, Jian-Jun Si, Jing Li, Di-Long Chen, Jian-Hua Ran
      Molecules.2021; 26(7): 1990.     CrossRef
    • Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy
      Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
      The Korean Journal of Internal Medicine.2021; 36(3): 557.     CrossRef
    • Biomolecular imaging of colorectal tumor lesions using a FITC-labeled scFv-Cκ fragment antibody
      Hyung Il Kim, Jinhyeon Kim, Hyori Kim, Hyeri Lee, Yong Sik Yoon, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Suk-Kyun Yang, Sun Young Kim, Seung-Jae Myung
      Scientific Reports.2021;[Epub]     CrossRef
    • Comparison of the Effects of Diltiazem Gel with Lidocaine Gel on Reducing Pain and Discomfort in Patients Undergoing Rectosigmoidoscopy: A Randomized Double-blinded Clinical Trial
      Ahmad Hormati, Mohammad Reza Ghadir, Faezeh Alemi, Seyed Saeid Sarkeshikian, Abolfazl Mohammadbeigi, Sajjad Ahmadpour, Seyed Jalal Eshagh-Hoseini
      Current Drug Therapy.2021; 16(2): 204.     CrossRef
    • A Comparative Study Evaluating the Incidence of Colorectal Neoplasia(s) in Candidates for Bariatric Surgery by Screening Colonoscopy, 40–49 Versus 50–65 Years Old: a Preliminary Study
      Toygar Toydemir, Görkem Özgen, İsmail Çalıkoğlu, Özdal Ersoy, Mehmet Ali Yerdel
      Obesity Surgery.2019; 29(8): 2430.     CrossRef
    • Impact of obesity and metabolic abnormalities on the risk of metachronous colorectal neoplasia after polypectomy in men
      Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
      Journal of Gastroenterology and Hepatology.2019; 34(9): 1504.     CrossRef
    • A Randomized Controlled Trial Comparing Colonoscopic Enema With Additional Oral Preparation as a Salvage for Inadequate Bowel Cleansing Before Colonoscopy
      Hyo-Joon Yang, Dong Il Park, Soo-Kyung Park, Sunyong Kim, Taeheon Lee, Yunho Jung, Chang Soo Eun, Dong Soo Han
      Journal of Clinical Gastroenterology.2019; 53(8): e308.     CrossRef
    • Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol + ascorbate or oral sulfate solution
      Alessandro Repici, Emmanuel Coron, Prateek Sharma, Cristiano Spada, Milena Di Leo, Colin L. Noble, Jürgen Gschossmann, Ana Bargalló García, Daniel C. Baumgart
      Digestive and Liver Disease.2019; 51(12): 1671.     CrossRef
    • Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas
      Nam Hee Kim, Yoon Suk Jung, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn
      American Journal of Gastroenterology.2019; 114(10): 1657.     CrossRef
    • Confounders in Adenoma Detection at Initial Screening Colonoscopy: A Factor in the Assessment of Racial Disparities as a Risk for Colon Cancer
      Yakira David, Lorenzo Ottaviano, Jihye Park, Sadat Iqbal, Michelle Likhtshteyn, Samir Kumar, Helen Lyo, Ayanna E. Lewis, Brandon E. Lung, Jesse T. Frye, Li Huang, Ellen Li, Jie Yang, Laura Martello, Shivakumar Vignesh, Joshua D. Miller, Michele Follen, Ev
      Journal of Cancer Therapy.2019; 10(04): 269.     CrossRef
    • Right Versus Left Colon Cancer: Resectable and Metastatic Disease
      Michele Ghidini, Fausto Petrelli, Gianluca Tomasello
      Current Treatment Options in Oncology.2018;[Epub]     CrossRef
    • Risk of developing metachronous advanced colorectal neoplasia after colonoscopic polypectomy in patients aged 30 to 39 and 40 to 49 years
      Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
      Gastrointestinal Endoscopy.2018; 88(4): 715.     CrossRef
    • The risk of colorectal neoplasia can be different according to the types of family members affected by colorectal cancer
      Nam Hee Kim, Hyo‐Joon Yang, Soo‐Kyung Park, Jung Ho Park, Dong Il Park, Chong Il Sohn, Yoon Suk Jung
      Journal of Gastroenterology and Hepatology.2018; 33(2): 397.     CrossRef
    • Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer
      Hee Seung Lee, Sung Bae Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
      Gastrointestinal Endoscopy.2018; 87(3): 688.     CrossRef
    • Characteristics of right-sided colonic neoplasia and colonoscopy barriers limiting their early detection and prognosis: a review of the literature
      Wolfgang Fischbach, Rory Elsome, Bharat Amlani
      Expert Review of Gastroenterology & Hepatology.2018; 12(6): 585.     CrossRef
    • Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results
      Yoon Suk Jung, Chan Hyuk Park, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Tatsuo Shimosawa
      PLOS ONE.2018; 13(1): e0191125.     CrossRef
    • Prospective analysis of delayed colorectal post-polypectomy bleeding
      Soo-Kyung Park, Jeong Yeon Seo, Min-Gu Lee, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Hungdai Kim, Hyung Ook Kim, Kyung Uk Jung, Ho-Kyung Chun, Dong Il Park
      Surgical Endoscopy.2018; 32(7): 3282.     CrossRef
    • Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia
      Hyun Gun Kim, Young-Seok Cho, Jae Myung Cha, Jeong Eun Shin, Kyeong Ok Kim, Hyo-Joon Yang, Hoon Sup Koo, Young-Eun Joo, Sun-Jin Boo
      Gastrointestinal Endoscopy.2018; 87(3): 666.     CrossRef
    • Risk Factors for False Fecal Immunochemical Test Results in Colorectal Cancer Screening
      Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
      Journal of Clinical Gastroenterology.2017; 51(2): 151.     CrossRef
    • Colonoscopy and Flexible Sigmoidoscopy in Colorectal Cancer Screening and Surveillance
      Juliana Yang, John H. Kwon
      Current Colorectal Cancer Reports.2017; 13(4): 284.     CrossRef
    • Randomized trial comparing oral sulfate solution with 4‐L polyethylene glycol administered in a split dose as preparation for colonoscopy
      Hyo‐Joon Yang, Soo‐Kyung Park, Jee Hyun Kim, Jong Pil Im, Dong Han Yeom, Geom Seog Seo, Dong Il Park
      Journal of Gastroenterology and Hepatology.2017; 32(1): 12.     CrossRef
    • Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models
      Rebecca A. Hubbard, Eric Johnson, Jessica Chubak, Karen J. Wernli, Aruna Kamineni, Andy Bogart, Carolyn M. Rutter
      Health Services and Outcomes Research Methodology.2017; 17(2): 101.     CrossRef
    • Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea
      Young-Hak Cho, Dae Ho Kim, Jae Myung Cha, Yoon Tae Jeen, Jeong Seop Moon, Jin-Oh Kim, Sang Kil Lee, Yu Kyung Cho, Jong Pil Im, Jae Young Jang, Jeong Eun Shin, Soon Man Yoon, Yunho Jung, Eun Sun Kim, Kang Nyeong Lee, Soo-Jeong Cho, Yeol Kim, Bo Young Park
      Gut and Liver.2017; 11(6): 821.     CrossRef
    • External Validation of the Endoscopic Features of Sessile Serrated Adenomas in Expert and Trainee Colonoscopists
      Hyo-Joon Yang, Jeong In Lee, Soo-Kyung Park, Yoon Suk Jung, Jin Hee Sohn, Kyu Yong Choi, Dong Il Park
      Clinical Endoscopy.2017; 50(3): 279.     CrossRef
    • Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
      Mengjie Jiang, Yinuo Tan, Xiaofen Li, Jianfei Fu, Hanguang Hu, Xianyun Ye, Ying Cao, Jinghong Xu, Ying Yuan
      Gastroenterology Research and Practice.2017; 2017: 1.     CrossRef
    • Prospective Analysis of Minor Adverse Events After Colon Polypectomy
      Soo-Kyung Park, Min-Gu Lee, Seok Hyeon Jeong, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Hungdai Kim, Hyung Ook Kim, Kyung Uk Jeong, Ho-Kyung Chun, Dong Il Park
      Digestive Diseases and Sciences.2017; 62(8): 2113.     CrossRef
    • Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies
      Nam Hee Kim, Jung Yul Suh, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
      Yonsei Medical Journal.2017; 58(2): 347.     CrossRef
    • Risk factors of nonadherence to colonoscopy surveillance after polypectomy and its impact on clinical outcomes: a KASID multicenter study
      Chung Hyun Tae, Chang Mo Moon, Seong-Eun Kim, Sung-Ae Jung, Chang Soo Eun, Jae Jun Park, Geom Seog Seo, Jae Myung Cha, Sung Chul Park, Jaeyoung Chun, Hyun Jung Lee, Yunho Jung, Jin Oh Kim, Young-Eun Joo, Dong Il Park
      Journal of Gastroenterology.2017; 52(7): 809.     CrossRef
    • Association Between Low Relative Muscle Mass and the Risk of Colorectal Neoplasms
      Yoon Suk Jung, Nam Hee Kim, Seungho Ryu, Jung Ho Park, Dong Il Park, Chong Il Sohn
      Journal of Clinical Gastroenterology.2017; 51(10): e83.     CrossRef
    • Risk factors of missed colorectal lesions after colonoscopy
      Jeonghun Lee, Sung Won Park, You Sun Kim, Kyung Jin Lee, Hyun Sung, Pil Hun Song, Won Jae Yoon, Jeong Seop Moon
      Medicine.2017; 96(27): e7468.     CrossRef
    • Identifying the optimal strategy for screening of advanced colorectal neoplasia
      Yoon Suk Jung, Chan Hyuk Park, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn
      Journal of Gastroenterology and Hepatology.2017; 32(5): 1003.     CrossRef
    • Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2)
      Jaeil Kim, Eun-ju Do, Helen Moinova, Sang Mun Bae, Ja Young Kang, Seung-Mo Hong, Stephen P. Fink, Jinmyoung Joo, Young-Ah Suh, Se Jin Jang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Jaewon Choe, Suk-Kyun Yang, Sanfo
      Neoplasia.2017; 19(10): 805.     CrossRef
    • Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
      Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
      Yonsei Medical Journal.2017; 58(1): 150.     CrossRef
    • Metformin use and the risk of colorectal adenoma: A systematic review and meta‐analysis
      Yoon Suk Jung, Chan Hyuk Park, Chang Soo Eun, Dong Il Park, Dong Soo Han
      Journal of Gastroenterology and Hepatology.2017; 32(5): 957.     CrossRef
    • Comparison of adenoma detection rate and adenoma per colonoscopy as a quality indicator of colonoscopy
      Soo-Kyung Park, Hyun-Young Kim, Chang Kyun Lee, Jae Myung Cha, Chang Soo Eun, Dong Soo Han, Bo-In Lee, Jeong Eun Shin, Dong Il Park
      Scandinavian Journal of Gastroenterology.2016; 51(7): 886.     CrossRef
    • Does Polyethylene Glycol (PEG) Plus Ascorbic Acid Induce More Mucosal Injuries than Split-Dose 4-L PEG during Bowel Preparation?
      Min Sung Kim, Jongha Park, Jae hyun Park, Hyung Jun Kim, Hyun Jeong Jang, Hee Rin Joo, Ji Yeon Kim, Joon Hyuk Choi, Nae Yun Heo, Seung Ha Park, Tae Oh Kim, Sung Yeon Yang
      Gut and Liver.2016; 10(2): 237.     CrossRef
    • Risk of Advanced Colorectal Neoplasia According to the Number of High-Risk Findings at Index Colonoscopy: A Korean Association for the Study of Intestinal Disease (KASID) Study
      Yoon Suk Jung, Dong Il Park, Won Hee Kim, Chang Soo Eun, Soo-Kyung Park, Bong Min Ko, Geom Seog Seo, Jae Myung Cha, Jae Jun Park, Kyeong Ok Kim, Chang Mo Moon, Yunho Jung, Eun Soo Kim, Seong Ran Jeon, Chang Kyun Lee
      Digestive Diseases and Sciences.2016; 61(6): 1661.     CrossRef
    • A wide variation of the quality of colonoscopy reporting system in the real clinical practice in southeastern area of Korea
      Jung Min Lee, Yu Jin Kang, Eun Soo Kim, Yoo Jin Lee, Kyung Sik Park, Kwang Bum Cho, Seong Woo Jeon, Min Kyu Jung, Hyun Seok Lee, Eun Young Kim, Jin Tae Jung, Byung Ik Jang, Kyeong Ok Kim, Yun Jin Chung, Chang Hun Yang
      Intestinal Research.2016; 14(4): 351.     CrossRef
    • Metabolic syndrome is a risk factor for adenoma occurrence at surveillance colonoscopy
      Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
      Medicine.2016; 95(32): e4454.     CrossRef
    • Risk Factors Such as Male Sex, Smoking, Metabolic Syndrome, Obesity, and Fatty Liver Do Not Justify Screening Colonoscopies Before Age 45
      Yoon Suk Jung, Kyung Eun Yun, Yoosoo Chang, Seungho Ryu, Dong Il Park
      Digestive Diseases and Sciences.2016; 61(4): 1021.     CrossRef
    • Comparison of Efficacy of Prophylactic Endoscopic Therapies for Postpolypectomy Bleeding in the Colorectum: A Systematic Review and Network Meta-Analysis
      Chan Hyuk Park, Yoon Suk Jung, Eunwoo Nam, Chang Soo Eun, Dong Il Park, Dong Soo Han
      American Journal of Gastroenterology.2016; 111(9): 1230.     CrossRef
    • Different risk factors for advanced colorectal neoplasm in young adults
      Ji Yeon Kim, Yoon Suk Jung, Jung Ho Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi, Dong Il Park
      World Journal of Gastroenterology.2016; 22(13): 3611.     CrossRef
    • Risk of developing advanced colorectal neoplasia after removing high‐risk adenoma detected at index colonoscopy in young patients: A KASID study
      Soo‐Kyung Park, Nam Hee Kim, Yoon Suk Jung, Won Hee Kim, Chang Soo Eun, Bong Min Ko, Geom Seog Seo, Jae Myung Cha, Jae Jun Park, Kyeong Ok Kim, Chang Mo Moon, Yoonho Jung, Eun Soo Kim, Seong Ran Jeon, Chang Kyun Lee, Dong Il Park
      Journal of Gastroenterology and Hepatology.2016; 31(1): 138.     CrossRef
    • Weight Change and Obesity Are Associated with a Risk of Adenoma Recurrence
      Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi
      Digestive Diseases and Sciences.2016; 61(9): 2694.     CrossRef
    • Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia
      Nam Hee Kim, Min-Jung Kwon, Hyun-young Kim, Taeheon Lee, Seok Hyeon Jeong, Dong Il Park, Kyuyong Choi, Yoon Suk Jung
      Digestive and Liver Disease.2016; 48(6): 667.     CrossRef
    • Clinical Characteristics and Mortality of Life-Threatening Events Requiring Cardiopulmonary Resuscitation in Gastrointestinal Endoscopy Units
      Hye Min Park, Eun Soo Kim, Sang Min Lee, Yoo Jin Lee, Kyung Sik Park, Kwang Bum Cho, Eun Young Kim, Jin Tae Jung, Kyeong Ok Kim, Byung Ik Jang, Yun Jin Jung, Chang Hun Yang, Hyun Seok Lee, Seong Woo Jeon
      Medicine.2015; 94(43): e1934.     CrossRef
    • Developments in Screening Tests and Strategies for Colorectal Cancer
      Justin L. Sovich, Zachary Sartor, Subhasis Misra
      BioMed Research International.2015; 2015: 1.     CrossRef
    • Race and ethnicity considerations in GI endoscopy
      Amy Wang, Aasma Shaukat, Ruben D. Acosta, David H. Bruining, Vinay Chandrasekhara, Krishnavel V. Chathadi, Mohamad A. Eloubeidi, Robert D. Fanelli, Ashley L. Faulx, Lisa Fonkalsrud, Suryakanth R. Gurudu, Loralee R. Kelsey, Mouen A. Khashab, Shivangi Kotha
      Gastrointestinal Endoscopy.2015; 82(4): 593.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Impact of Sigmoidoscopy and Colonoscopy on Colorectal Cancer Incidence and Mortality: An Evidence-Based Review of Published Prospective and Retrospective Studies
      Intest Res. 2014;12(4):268-274.   Published online October 27, 2014
      DOI: https://doi.org/10.5217/ir.2014.12.4.268
      Close
    • XML DownloadXML Download
    Impact of Sigmoidoscopy and Colonoscopy on Colorectal Cancer Incidence and Mortality: An Evidence-Based Review of Published Prospective and Retrospective Studies
    Impact of Sigmoidoscopy and Colonoscopy on Colorectal Cancer Incidence and Mortality: An Evidence-Based Review of Published Prospective and Retrospective Studies

    Prospective Studies on the Impact of Sigmoidoscopy or Colonoscopy on Colorectal Cancer (CRC) Incidence and Mortality

    *Reduction in CRC mortality and all-cause mortality was statistically significant for the screened group in per-protocol analysis but not in intention-to-treat analysis.

    RCT, Randomized controlled trial; SEER, Surveillance, Epidemiology, and End Results; Δ, change; NA, not available.

    Retrospective Studies on the Impact of Sigmoidoscopy or Colonoscopy on Colorectal Cancer (CRC) Incidence and Mortality

    *Rectal cancers were excluded from this study.

    †Statistically significant for colonoscopy but not sigmoidoscopy.

    AN, advanced neoplasia; NA, not available; Δ, change.
    Table 1 Prospective Studies on the Impact of Sigmoidoscopy or Colonoscopy on Colorectal Cancer (CRC) Incidence and Mortality

    *Reduction in CRC mortality and all-cause mortality was statistically significant for the screened group in per-protocol analysis but not in intention-to-treat analysis.

    RCT, Randomized controlled trial; SEER, Surveillance, Epidemiology, and End Results; Δ, change; NA, not available.

    Table 2 Retrospective Studies on the Impact of Sigmoidoscopy or Colonoscopy on Colorectal Cancer (CRC) Incidence and Mortality

    *Rectal cancers were excluded from this study.

    †Statistically significant for colonoscopy but not sigmoidoscopy.

    AN, advanced neoplasia; NA, not available; Δ, change.

    Table 1

    Table 2

    Intest Res : Intestinal Research
    © Korean Association for the Study of Intestinal Diseases.
    Close layer
    TOP